Company: MYGN
Filing Date: 2025-10-07
Form Type: 8-K
Source: 0000899923-25-000096
Chunk: 1

Company: MYRIAD GENETICS INC
Filing Date: 2025-10-07
Form: 8-K
Item: Item 9.01
Chunk 1
---
ITEM 9.01 Financial Statements and Exhibits.

  Exhibit      Description                                                                                                                    
  Number                                                                                                                                      
  10.1+        Separation Agreement and Release of Claims, dated October 1, 2025, by and between Myriad Genetics, Inc. and Scott J. Leffler.  
 ──────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
  104          Cover Page Interactive Data File (embedded within the Inline XBRL document).                                                   

+ Management contract or compensatory plan arrangement.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

  MYRIAD GENETICS, INC.                               
  By:                        /s/ Benjamin R. Wheeler  
                             Benjamin R. Wheeler      
                             Chief Financial Officer